Physician profile
Mario E Carbonell
NPI 1639150048
$1,609.11
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $452 · 2020: $533 · 2021: $360 · 2022: $227 · 2023: $36.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $36.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $36.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $495.59 | 2019-2022 | |
| Lilly USA, LLC | $213.19 | 2020-2022 | |
| Amarin Pharma, INC. | $196.47 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $141.88 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $111.50 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $106.25 | 2019-2020 | |
| Pfizer INC. | $45.34 | 2020-2022 | |
| Abbvie INC. | $42.28 | 2021-2023 | Vraylar |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.99 | 2019 | |
| Ge Healthcare | $25.45 | 2019 | |
| Abbott Laboratories | $25.09 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.62 | 2019 | |
| Janssen Pharmaceuticals, INC | $20.56 | 2021 | |
| Edwards Lifesciences Corporation | $19.15 | 2020 | |
| Astellas Pharma US INC | $18.39 | 2023 | Veozah |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $17.01 | 2020 | |
| Allergan, INC. | $15.96 | 2019 | |
| Merck Sharp & Dohme LLC | $14.97 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.83 | 2021 | |
| Glaxosmithkline, LLC. | $13.51 | 2020 | |
| Amgen INC. | $13.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mario Carbonell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.